AstraZeneca’s cell lung cancer drug sent for EU approval



AstraZeneca Plc.’s treatment for patients with unresectable non-small cell lung cancer Tagrisso gained key recommendation for approval in the European Union, the company announced on Monday.The Commit…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento